FIELD: medicine.
SUBSTANCE: disclosed method refers to medicine, namely to ophthalmology. Long-continued delivery of active retinoid to posterior pole of mammal's eye enables treatment or prevention of proliferative vitreoretinopathy, age-related macular degeneration, and pigmentary retinopathy. It involves subconjunctival or periocular delivery of prodrug retinoid in effective amount actually being ether derivative of active drug 10 times more active than prodrug.
EFFECT: method allows for reduced risk of potential complications with decreased concentration of introduced drug.
13 cl, 10 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
| METHOD OF TREATING ATROPHIC AGE-RELATED MACULAR DEGENERATION | 2009 |
|
RU2521338C9 |
| METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION | 2009 |
|
RU2668371C2 |
| INTRAOCULAR SYSTEMS OF SUSTAINED-RELEASE DRUG DELIVERY AND METHOD OF TREATING OPHTHALMIC DISEASES | 2010 |
|
RU2532333C2 |
| METHOD OF TREATING ELEVATED INTRAOCULAR PRESSURE USING INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEM | 2014 |
|
RU2664686C2 |
| PREVENTIVE AND THERAPEUTIC AGENT FOR POSTERIOR EYE DISEASES | 2008 |
|
RU2470635C2 |
| IMPLANT FOR PROLONGED DRUG DELIVERY | 2014 |
|
RU2641021C2 |
| COMPOSITIONS AND METHODS FOR INSERTION OF TUBULIN-BINDING AGENTS FOR EYE DISEASE THERAPY | 2002 |
|
RU2354398C2 |
| COMPOSITIONS AND WAYS OF INJECTIONS OF AGENTS BINDING TUBULIN, FOR TREATMENT OF EYE DISEASES | 2004 |
|
RU2359693C2 |
| TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS | 2018 |
|
RU2815482C2 |
